ELDN
Eledon Pharmaceuticals Inc
2.50$
+2.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | – | – | 100.0% | – | – | – | – | – | – | – | – | – | 100.0% | – | 100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 38.3% | 37.5% | 38.3% | – | – | 50,833.3% | – | – | – | – | – | – | – | – | – | 17.3% | – | 22.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -38.3% | -37.5% | -38.3% | – | – | -50,833.3% | – | – | – | – | – | – | – | – | – | -17.3% | – | -22.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 512.5% | 2,530.0% | 4,710.8% | – | – | 5,151,666.7% | – | – | – | – | – | – | – | – | – | 1,804.6% | – | 4,668.8% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3,109.2% | 2,768.3% | 2,793.3% | – | – | 2,669,166.7% | – | – | – | – | – | – | – | – | – | 785.0% | – | 1,762.5% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5,123.3% | 5,290.0% | 7,504.2% | – | – | 7,820,833.3% | – | – | – | – | – | – | – | – | – | 2,589.6% | – | 6,431.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5,123.3% | -5,290.0% | -7,504.2% | – | – | -7,820,833.3% | – | – | – | – | – | – | – | – | – | -2,589.6% | – | -6,431.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4,024.2% | – | – | – | 7,815,630.8% | – | – | – | – | – | – | – | – | – | 60.4% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5,120.0% | -5,256.7% | -7,500.0% | – | – | -7,820,833.3% | – | – | – | – | – | – | – | – | – | -8,019.1% | – | -11,506.8% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,501.7% | -336.7% | -417.5% | – | – | -482,500.0% | – | – | – | – | – | – | – | – | – | 9.2% | – | 112.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5,120.0% | -4,920.0% | -7,082.5% | – | – | -7,338,333.3% | – | – | – | – | – | – | – | – | – | -8,019.1% | – | -11,619.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3,583.3% | -5,260.8% | -7,465.8% | – | – | -7,770,000.0% | – | – | – | – | – | – | – | – | – | -8,001.8% | – | -11,483.9% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.